Stay updated on ERADICATE-HF: Clinical Trial in HFpEF and HFrEF
Sign up to get notified when there's something new on the ERADICATE-HF: Clinical Trial in HFpEF and HFrEF page.

Latest updates to the ERADICATE-HF: Clinical Trial in HFpEF and HFrEF page
- CheckyesterdayChange DetectedThe webpage has been updated to include new results and measurements related to the effects of ertugliflozin, including various renal and cardiovascular parameters, while removing previous measurements and results that are no longer relevant.SummaryDifference23%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to include new details about a clinical trial involving ertugliflozin for patients with Type 2 Diabetes Mellitus, including the study's randomization process and collaborators. Notably, the previous detailed description of the study's aims and mechanisms has been removed.SummaryDifference32%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to ERADICATE-HF: Clinical Trial in HFpEF and HFrEF
Enter your email address, and we'll notify you when there's something new on the ERADICATE-HF: Clinical Trial in HFpEF and HFrEF page.